SCHEMBL20124183

SCHEMBL20124183

CC(C)(S)CC(=O)NC1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 4/20 0.50
GNAI3 P08754 1/20 0.50
GNAO1 P09471 1/20 0.50
GNAI1 P63096 1/20 0.50
POLB P06746 1/20 0.46
HSD11B1 P28845 3/20 0.42
CHRM3 P20309 2/20 0.41
CHRM5 P08912 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
SSTR1 P30872 1/20 0.39
SSTR4 P31391 1/20 0.39
EPHX2 P34913 1/20 0.37
SMYD3 Q9H7B4 2/20 0.36
CHRM1 P11229 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM1A O60341 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8230248 0.86 EPHX1 (0.53) EPHX1GNAI3GNAO1GNAI1POLB
SCHEMBL23080304 0.84 SMN1; SMN2 (0.47) EPHX1HSD11B1EPHX2SMN1; SMN2HPGD
SCHEMBL12336001 0.81 GNAI3 (0.53) EPHX1GNAI3GNAO1GNAI1POLB
SCHEMBL12308796 0.78 GNAI3 (0.46) EPHX1GNAI3GNAO1GNAI1POLB
SCHEMBL18531851 0.78 GNAI3 (0.60) EPHX1GNAI3GNAO1GNAI1POLB
SCHEMBL617591 0.76 GNAI3 (0.62) EPHX1GNAI3GNAO1GNAI1POLB
Hydrochloric Acid SCHEMBL6163168 0.74 GNAI3 (0.65) EPHX1GNAI3GNAO1GNAI1POLB
SCHEMBL27224567 0.74 EPHX1 (0.57) EPHX1GNAI3GNAO1GNAI1POLB
SCHEMBL5106542 0.74 EPHX1 (0.61) EPHX1GNAI3GNAO1GNAI1POLB
Pivalate SCHEMBL28282777 0.73 GNAI3 (0.48) EPHX1GNAI3GNAO1GNAI1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488532-B1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2018-05-09 EP disclosed